Beijing Strong Biotechnologies Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Strong Biotechnologies Inc with three other
companies in this sector in China:
Beijing Leadman Biochemistry Co Ltd
sales of 644.09 million Chinese Renmimbi [US$93.19 million]
Guangdong Hybribio Biotech Co Ltd
(580.35 million Chinese Renmimbi [US$83.97 million]
of which 107%
was Molecular Diagnostic Reagents and Suppor), and
Getein Biotech Inc
(686.24 million Chinese Renmimbi [US$99.28 million]
of which 92%
was In-vitro diagnostics).
Beijing Strong Biotechnologies Inc reported sales of 774.18 million Chinese Renmimbi (US$112.01 million)
December of 2018.
increase of 11.5%
versus 2017, when the company's sales were 694.28 million Chinese Renmimbi.
Sales at Beijing Strong Biotechnologies Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 74%).